News

As per the terms of the agreement, Medicis is responsible to pay sum of $20m as an upfront payment to Lupin. The tie up allows Lupin to develop

Fampyra is a prolonged-release (sustained release) tablet formulation of the drug fampridine (4-aminopyridine, 4-AP or dalfampridine). Studies reveal that the sustained release formulation increases conduction of damaged nerves,

The company expects to recruit around 10 patients in the trial with an aim to establish the response rate to the therapy. The trial is intended to evaluate

Probiotic chews contains 1 billion bacteria per serving and are of good taste due to the presence of natural sweeteners and flavanoids. Probiotic bacteria promote digestive health, immune

AssuriTEA Green is a solvent-based tea extract which provides green tea polyphenols — EGCG, non-EGCG catechins, and non-catechin antioxidants. Kemin Industries Health division senior vice president Linda Fullmer

Under the agreement, both the parties are expected to leverage their capabilities for supporting the development of TB vaccines. The scope of potential activities will cover the full

Under a development and manufacturing deal, Laureate will be responsible for manufacturing the biosimilar product for clinical trials through 2013. Laureate anticipates for supplying the first batch of

Genesis Biopharma’s Contego is an autologous cell therapy product indicated for the treatment for Stage IV metastatic melanoma. Lonza Therapeutic Cell Solutions head David Smith said Lonza is

The approval has been granted for 200mg, 1gm and 2gm dosage strengths. Gemcitabine for Injection USP, which is a nucleoside metabolite inhibitor that exhibits antitumor activity, is the